ProCE Banner Activity

Planning Therapy for High-Risk HER2-Positive Early-Stage Breast Cancer: Expert Viewpoint

Slideset Download
Downloadable slides by Lee Schwartzberg, MD, FACP on planning therapy for patients with high-risk HER2+ Early Breast Cancer

Released: May 12, 2021

Expiration: May 11, 2022

No longer available for credit.

Share

Faculty

Lee Schwartzberg

Lee Schwartzberg, MD

Professor of Medicine
Chief
Division of Hematology and Oncology
University of Tennessee Health Science Center
Memphis, Tennessee
Executive Director
West Cancer Center
Germantown, Tennessee

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Puma Biotechnology, Inc.

Faculty Disclosure

Primary Author

Lee Schwartzberg, MD

Professor of Medicine
Chief
Division of Hematology and Oncology
University of Tennessee Health Science Center
Memphis, Tennessee
Executive Director
West Cancer Center
Germantown, Tennessee